Mission statement · Company scope
“Our mission is to apply the Versamune ® platform, our proprietary and versatile immunotherapy technology, to develop a new generation of immuno-oncology products that are effective and safe across a broad range of cancer types.”
In use2020 – now1 sighting
First seenMar 2020Added
Last seenMar 2020Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary)
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Technical
- Length
- 35 words · reading grade 21.3
- Review status
- auto accepted · classifier rules-v0
- Quality score
- 0.77
- Record
- st_b11f68539d7281c1
- Classification confidence
- 0.95
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2020-03-27 · sec_sentence · 10-K · accession 0001140361-20-007252
View filing ↗0 to compareCompare